Association of transforming growth factor-β1 T869C, G915C, and C509T gene polymorphisms with rheumatoid arthritis risk

References

• Qi J, Ye X, Ren G, et al. Pharmacological efficacy of anti-IL-1beta scFv, Fab and full-length antibodies in treatment of rheumatoid arthritis. Mol Immunol 2013;57:59–65
   Google Scholar
• Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor β in human disease. N Engl J Med. 2000;342:1350–8
   PubMed Web of Science ®Google Scholar
• Li MO, Wan YY, Sanjabi S, et al. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 2006;24:99–146
   PubMed Web of Science ®Google Scholar
• Manolova I, Gerenova J, Ivanova M. Serum levels of transforming growth factor-beta1 (TGF-beta1) in patients with systemic lupus erythematosus and Hashimoto's thyroiditis. Eur Cytokine Netw 2013;24:69–74
   PubMed Web of Science ®Google Scholar
• Gagliardo R, Chanez P, Gjomarkaj M, et al. The role of transforming growth factor-beta1 in airway inflammation of childhood asthma. Int J Immunopathol Pharmacol 2013;26:725–38
   PubMedGoogle Scholar
• Nakamura-Wakatsuki T, Oyama N, Yamamoto T. Local injection of latency-associated peptide, a linker propeptide specific for active form of transforming growth factor-beta1, inhibits dermal sclerosis in bleomycin-induced murine scleroderma. Exp Dermatol 2012;21:189–94
   PubMed Web of Science ®Google Scholar
• Furuzawa-Carballeda J, Ortiz-Avalos M, Lima G, et al. Subcutaneous administration of polymerized type I collagen downregulates interleukin (IL)-17A, IL-22 and transforming growth factor-beta1 expression, and increases Foxp3-expressing cells in localized scleroderma. Clin Exp Dermatol 2012;37:599–609
   PubMed Web of Science ®Google Scholar
• Brennan FM, Chantry D, Turner M, et al. Detection of transforming growth factor-beta in rheumatoid arthritis synovial tissue: lack of effect on spontaneous cytokine production in joint cell cultures. Clin Exp Immunol 1990;81:278–85
   PubMed Web of Science ®Google Scholar
• Mieliauskaite D, Venalis P, Dumalakiene I, et al. Relationship between serum levels of TGF-beta1 and clinical parameters in patients with rheumatoid arthritis and Sjogren's syndrome secondary to rheumatoid arthritis. Autoimmunity 2009;42:356–8
   PubMed Web of Science ®Google Scholar
• Song HY, Kim MY, Kim KH, et al. Synovial fluid of patients with rheumatoid arthritis induces alpha-smooth muscle actin in human adipose tissue-derived mesenchymal stem cells through a TGF-beta1-dependent mechanism. Exp Mol Med 2010;42:565–73
   Google Scholar
• Warstat K, Hoberg M, Rudert M, et al. Transforming growth factor beta1 and laminin-111 cooperate in the induction of interleukin-16 expression in synovial fibroblasts from patients with rheumatoid arthritis. Ann Rheum Dis 2010;69:270–5
   Google Scholar
• Bewick MA, Conlon MS, Lafrenie RM. Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer. J Clin Oncol 2006;24:5645–51
   PubMed Web of Science ®Google Scholar
• Bewick MA, Conlon MS, Lafrenie RM. Polymorphisms in manganese superoxide dismutase, myeloperoxidase and glutathione-S-transferase and survival after treatment for metastatic breast cancer. Breast Cancer Res Treat 2008;111:93–101
   PubMed Web of Science ®Google Scholar
• Bewick MA, Lafrenie RM, Conlon MS. Nucleotide excision repair polymorphisms and survival outcome for patients with metastatic breast cancer. J Cancer Res Clin Oncol 2011;137:543–50
   PubMed Web of Science ®Google Scholar
• Chang WW, Su H, He L, et al. Association between transforming growth factor-beta1 T869C polymorphism and rheumatoid arthritis: a meta-analysis. Rheumatology (Oxford) 2010;49:652–6
   PubMed Web of Science ®Google Scholar
• Zhou TB, Xu HL, Yin SS. Association between endothelial nitric oxide synthase Glu298Asp gene polymorphism and diabetic nephropathy susceptibility. Ren Fail 2013;35:173–8
   PubMed Web of Science ®Google Scholar
• Zhou TB, Yin SS. Association of matrix metalloproteinase-9 level with the risk of renal involvement for Henoch-Schonlein purpura in children. Ren Fail 2013;35:425–9
   PubMed Web of Science ®Google Scholar
• Zhou TB, Yin SS, Qin YH. Association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease susceptibility. J Renin Angiotensin Aldosterone Syst 2014;15:22–31
   PubMed Web of Science ®Google Scholar
• Zhou TB, Qin YH, Su LN, et al. ACE I/D gene polymorphism can't predict the steroid responsiveness in Asian children with idiopathic nephrotic syndrome: a meta-analysis. PLoS One 2011;6:e19599
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088–101
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629–34
   PubMed Web of Science ®Google Scholar
• Alayli G, Kara N, Tander B, et al. Association of transforming growth factor beta1 gene polymorphism with rheumatoid arthritis in a Turkish population. Joint Bone Spine 2009;76:20–3
   PubMed Web of Science ®Google Scholar
• Kim SY, Han SW, Kim GW, et al. TGF-beta1 polymorphism determines the progression of joint damage in rheumatoid arthritis. Scand J Rheumatol 2004;33:389–94
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Murasawa A, Ito S, et al. Cytokine gene polymorphisms associated with rheumatoid arthritis and periodontitis in Japanese adults. J Periodontol 2009;80:792–9
   PubMed Web of Science ®Google Scholar
• Li Y, Liu C. To investigate reletionship of the polymorphisms patients with rheumatoid artllritis. Thesis for the degree of master. Zhengzhou: Zhengzhou University; 2011
   Google Scholar
• Munoz-Valle JF, Torres-Carrillo NM, Guzman-Guzman IP, et al. The functional class evaluated in rheumatoid arthritis is associated with soluble TGF-beta1 serum levels but not with G915C (Arg25Pro) TGF-beta1 polymorphism. Rheumatol Int 2012;32:367–72
   PubMed Web of Science ®Google Scholar
• Panoulas VF, Douglas KM, Smith JP, et al. Transforming growth factor-beta1 869T/C, but not interleukin-6 -174G/C, polymorphism associates with hypertension in rheumatoid arthritis. Rheumatology (Oxf) 2009;48:113–8
   PubMed Web of Science ®Google Scholar
• Pokorny V, Chau J, Wu L, et al. Transforming growth factor beta 1 gene (HSTGFB1) nucleotide T869C (codon 10) polymorphism is not associated with prevalence or severity of rheumatoid arthritis in a Caucasian population. Ann Rheum Dis 2003;62:907–8
   PubMed Web of Science ®Google Scholar
• Sugiura Y, Niimi T, Sato S, et al. Transforming growth factor beta1 gene polymorphism in rheumatoid arthritis. Ann Rheum Dis 2002;61:826–8
   PubMed Web of Science ®Google Scholar
• Wang Y, Xiao L, Zhou Y, et al. Gene polymorphisms of transforming growth factor-β1 with rheumatoid arthritis. Chin J Public Health 2007;23:1405–6
   Google Scholar
• Zhu Y, Liu F, Zhang F, et al. Correlation of transforming growth factor-β1 T869C polymorphism and rheumatoid arthritis in Chinese population. Jiangsu Med J 2006;32:1112–4
   Google Scholar
• Wan YN, Wang YJ, Yan JW, et al. The effect of TGF-beta1 polymorphism on systemic sclerosis: a systematic review and pooled analysis of available literature. Rheumatol Int 2013;33:2859–65
   Google Scholar
• Zhang J, Guan YL, Xiao Y, Zhang XW. A meta-analysis of the association of G915C, G800A, C509T gene polymorphism of transforming growth factor-beta1 with diabetic nephropathy risk. Ren Fail 2014;36:321–6
   Web of Science ®Google Scholar
• Li K, Xia F, Zhang K, et al. Association of a tgf-b1-509c/t polymorphism with gastric cancer risk: a meta-analysis. Ann Hum Genet 2013;77:1–8
   Google Scholar